Antimicrobial Metamaterial Platform

About EVOQ Nano

EVOQ Nano has developed a proprietary, high-energy laser ablation platform that overcomes traditional manufacturing barriers to produce uniform, stable spherical metamaterials at a consistent nanoscale size (10nm ±4). This platform enables the creation of materials with unique physical properties, including demonstrated broad-spectrum antimicrobial activity, without the need for chemical capping agents or ion emission. The company's technology, published in peer-reviewed journals, represents a potential breakthrough in nanomaterial production for therapeutic and industrial applications. As a private, likely pre-revenue entity, EVOQ's key challenge is translating its promising platform into commercialized products or partnerships.

Therapeutic Areas